Attached files
| file | filename |
|---|---|
| 10-K - PVCT 10-K 12-31-09 - PROVECTUS BIOPHARMACEUTICALS, INC. | pvct10k123109.htm |
| EX-23.1 - PVCT 10-K EX 23.1 12-31-09 - PROVECTUS BIOPHARMACEUTICALS, INC. | pvct10kex23_1.htm |
| EX-31.2 - PVCT 10-K EX 31.2 12-31-09 - PROVECTUS BIOPHARMACEUTICALS, INC. | pvct10kex31_2.htm |
| EX-31.1 - PVCT 10-K EX 31.1 12-31-09 - PROVECTUS BIOPHARMACEUTICALS, INC. | pvct10kex31_1.htm |
| EX-21.1 - PVCT 10-K EX 21.1 12-31-09 - PROVECTUS BIOPHARMACEUTICALS, INC. | pvct10kex21_1.htm |
Exhibit 32.1
Provectus
Pharmaceuticals, Inc.
Certification
Pursuant to 18 U.S.C. ss. 1350
Section
906 Certifications
Pursuant
to 18
U.S.C. ss. 1350, as enacted by Section 906 of the
Sarbanes-Oxley Act of 2002 (Public Law 107-204), the undersigned, H. Craig Dees,
Ph.D., the Chief Executive Officer of Provectus
Pharmaceuticals, Inc., a Nevada corporation (the "Company"), and
Peter R. Culpepper, the Chief Financial Officer of the Company, hereby certify
that:
1. The Company's Annual Report on
Form 10-K for the year ended December 31, 2009, as filed with the U.S.
Securities and Exchange Commission on the date hereof (the "Report"), fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
2. The information contained in
the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.
This Certification is signed on
March 31, 2010.
|
|
|
/s/ H. Craig Dees | |
| H. Craig Dees, Ph.D. | |||
|
Chief
Executive Officer
Provectus
Pharmaceuticals, Inc.
|
|||
|
|
/s/ Peter R. Culpepper | ||
| Peter R. Culpepper | |||
|
Chief
Financial Officer
Chief Operating Officer
Provectus Pharmaceuticals, Inc.
|
|||
A signed original of this written
statement required by Section 906 has been provided to Provectus
Pharmaceuticals, Inc. and will be retained by Provectus Pharmaceuticals, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.